Genetic regulation of circadian rhythms and the sleep/wake cycle in sleep disorders (a systematic review)
https://doi.org/10.25587/2587-5590-2026-2-102-123
Abstract
Sleep disorders are a group of pathologies that are difficult to differentiate and diagnose due to the presence of many features. It is noted that sleep disorders have symptomatic similarities with each other and with other diseases, and are also comorbid conditions, which may lead to difficulties in clarifying the diagnosis. Thanks to genome-wide association studies (GWAS) conducted in the previous 20 years, it was found that sleep and its disorders are genetically determined, partially inherited and polygenic. Circadian rhythms are an important mechanism for regulating the sleep/wake cycle, but they are also genetically determined. Circadian rhythms are regulated by clock genes, whose expression follows the circadian rhythm. Due to the above reasons, there is an urgent need to search for biomarkers capable of providing accurate information for the subsequent diagnosis of sleep disorders. This paper provides a review of currently published scientific studies describing genes and genetic variants (SNVs) directly involved in the genetic regulation of circadian rhythms and the sleep/wake cycle, as well as aberrantly expressed genes and SNVs, potentially biomarkers of sleep disorders, which may simplify the process of diagnosing this type of disorders.
About the Authors
A. A. Popov
Prof. V. F. Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation
Russian Federation
POPOV, Aleksandr Andreevich, laboratory assistant, Laboratory of Medical Genetics
Krasnoyarsk
E. E. Timechko
Prof. V. F. Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation
Russian Federation
TIMECHKO, Elena Evgenevna, junior researcher, Laboratory of Medical Genetics
Krasnoyarsk
A. M. Yakimov
Prof. V. F. Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation
Russian Federation
YAKIMOV, Aleksey Mihaylovich, junior researcher, Laboratory of Medical Genetics
Krasnoyarsk
A. A. Vasilieva
Prof. V. F. Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation
Russian Federation
VASILIEVA, Anastasia Aleksandrovna, junior researcher, Laboratory of Medical Genetics
Krasnoyarsk
V. V. Karnauhov
Prof. V. F. Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation
Russian Federation
KARNAUHOV, Vladislav Evgenevich, graduate student, Department of Medical Genetics and Clinical Neurophysiology IPE
Krasnoyarsk
D. V. Dmitrenko
Prof. V. F. Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation
Russian Federation
DMITRENKO, Diana Viktorovna, Head of Department of Medical Genetics and Clinical Neurophysiology IPE, Head of Laboratory of Medical Genetics
Krasnoyarsk
References
1. Lasch K, Joish VN, Zhu Y, et al. Validation of the sleep impact scale in patients with major depressive disorder and insomnia. Curr. Med. Res. Opin. 2009;25(7):1699–1710. DOI: 10.1185/03007990902973201.
2. Gauld C, Lopez R, Geoffroy PA, et al. A systematic analysis of ICSD-3 diagnostic criteria and proposal for further structured iteration. Sleep Med. Rev. 2021;58: 101439. DOI: 10.1016/j.smrv.2021.101439.
3. Pevernagie D. Future Treatment of Sleep Disorders: Syndromic Approach Versus Management of Treatable Traits? Sleep Med. Clin. 2021;16(3):465–473. DOI: 10.1016/j.jsmc.2021.05.005.
4. Garfield V. Sleep duration: A review of genome-wide association studies (GWAS) in adults from 2007 to 2020. Sleep Med. Rev. 2021;56:101413. DOI: 10.1016/j.smrv.2020.101413.
5. Madrid-Valero JJ, Gregory AM. Behaviour genetics and sleep: A narrative review of the last decade of quantitative and molecular genetic research in humans. Sleep Med. Rev. 2023;69:101769. DOI: 10.1016/j.smrv.2023.101769.
6. Steele TA, St Louis EK, Videnovic A, Auger RR. Circadian Rhythm Sleep–Wake Disorders: a Contemporary Review of Neurobiology, Treatment, and Dysregulation in Neurodegenerative Disease. Neurotherapeutics. 2021;18(1):53–74. DOI: 10.1007/s13311-021-01031-8.
7. Elgart M, Redline S, Sofer T. Machine and Deep Learning in Molecular and Genetic Aspects of Sleep Research. Neurotherapeutics. 2021;18(1):228–243. DOI: 10.1007/s13311-021-01014-9.
8. Dodet P, Sanapo F, Leu-Semenescu S, et al. Sleep Disorders in Adults with Prader–Willi Syndrome: Review of the Literature and Clinical Recommendations Based on the Experience of the French Reference Centre. J. Clin. Med. 2022;11(7):1986. DOI: 10.3390/jcm11071986.
9. Mehramiz M, Porter T, Laws SM, Rainey-Smith SR. Sleep, Sirtuin 1 and Alzheimer’s disease: A review. Aging Brain. 2022;2:100050. DOI: 10.1016/j.nbas.2022.100050.
10. Carroll CM, Benca RM. Upsetting the Balance: How Modifiable Risk Factors Contribute to the Progression of Alzheimer’s Disease. Biomolecules. 2024;14(3):274. DOI: 10.3390/biom14030274.
11. el Youssef N, Marchi A, Bartolomei F, et al. Sleep and epilepsy: A clinical and pathophysiological overview. Rev. Neurol. (Paris). 2023;179(7):687–702. DOI: 10.1016/j.neurol.2023.07.006.
12. Dziadkowiak E, Chojdak-łukasiewicz J, Olejniczak P, Paradowski B. Regulation of microRNA expression in sleep disorders in patients with epilepsy. Int. J. Mol. Sci. 2021;22(14):7370. DOI: 10.3390/ijms22147370.
13. Paz V, Dashti HS, Burgess S, Garfield V. Selection of genetic instruments in Mendelian randomisation studies of sleep traits. Sleep Med. 2023;112:342–351. DOI: 10.1016/j.sleep.2023.10.036.
14. BaHammam AS, Pirzada A. Timing Matters: The Interplay between Early Mealtime, Circadian Rhythms, Gene Expression, Circadian Hormones, and Metabolism–A Narrative Review. Clocks Sleep. 2023;5(3):507–535. DOI: 10.3390/clockssleep5030034.
15. Baillieul S, Denis C, Barateau L, et al. The multifaceted aspects of sleep and sleep-wake disorders following stroke. Rev. Neurol. (Paris). 2023;179(7):782–792. DOI: 10.1016/j.neurol.2023.08.004.
16. Liu WK, Kothare S, Jain S. Sleep and Epilepsy. Semin. Pediatr. Neurol. 2023;48:101087. DOI: 10.1016/j.spen.2023.101087.
17. Salminen A. Aryl hydrocarbon receptor (AhR) impairs circadian regulation: Impact on the aging process. Ageing Res. Rev. 2023;87:101928. DOI: 10.1016/j.arr.2023.101928.
18. Mațotă A-M, Bordeianu A, Severin E, Jidovu A. Exploring the Literature on Narcolepsy: Insights into the Sleep Disorder That Strikes during the Day. NeuroSci. 2023;4(4):263–279. DOI: 10.3390/neurosci4040022.
19. Kuang B, Li D, Lobbezoo F, et al. Associations between sleep bruxism and other sleep-related disorders in adults: a systematic review. Sleep Med. 2022;89:31–47. DOI: 10.1016/j.sleep.2021.11.008.
20. Lajoie AC, Lafontaine AL, Kimoff RJ, Kaminska M. Obstructive sleep apnea in neurodegenerative disorders: Current evidence in support of benefit from sleep apnea treatment. J. Clin. Med. 2020;9(2):297. DOI: 10.3390/jcm9020297.
21. Cirelli C. How sleep deprivation affects gene expression in the brain: a review of recent findings. J. Appl. Physiol. (1985) 2002;92(1):394–400. DOI: 10.1152/jappl.2002.92.1.394.
22. Cirelli C, Faraguna U, Tononi G. Changes in brain gene expression after long-term sleep deprivation. J. Neurochem. 2006;98(5):1632–1645. DOI: 10.1111/j.1471-4159.2006.04058.x.
23. Lane JM, Vlasac I, Anderson SG, et al. Genome-wide association analysis identifies novel loci for chronotype in 100,420 individuals from the UK Biobank. Nat. Commun. 2016;7:10889. DOI: 10.1038/ncomms10889.
24. Chang AM, Duffy JF, Buxton OM, et al. Chronotype Genetic Variant in PER2 is Associated with Intrinsic Circadian Period in Humans. Sci. Rep. 2019;9(1):5350. DOI: 10.1038/s41598-019-41712-1.
25. Pinilla L, Barbé F, de Gonzalo-Calvo D. MicroRNAs to guide medical decision-making in obstructive sleep apnea: A review. Sleep Med. Rev. 2021;59:101458. DOI: 10.1016/j.smrv.2021.101458.
26. Han F, Faraco J, Dong XS, et al. Genome wide analysis of narcolepsy in China implicates novel immune loci and reveals changes in association prior to versus after the 2009 H1N1 influenza pandemic. PLoS Genet. 2013;9(10):e1003880. DOI: 10.1371/journal.pgen.1003880.
27. Toffoli M, Dreussi E, Cecchin E, et al. SNCA 3’UTR genetic variants in patients with Parkinson’s disease and REM sleep behavior disorder. Neurol. Sci. 2017;38(7):1233–1240. DOI: 10.1007/s10072-017-2945-2.
28. Hida A, Kitamura S, Katayose Y, et al. Screening of clock gene polymorphisms demonstrates association of a PER3 polymorphism with morningness-eveningness preference and circadian rhythm sleep disorder. Sci. Rep. 2014;4:6309. DOI: 10.1038/srep06309.
29. Mansour HA, Wood J, Chowdari KV, et al. Associations between period 3 gene polymorphisms and sleep- /chronotype-related variables in patients with late-life insomnia. Chronobiol. Int. 2017;34(5):624–631. DOI: 10.1080/07420528.2017.1287083.
30. Kripke DF, Kline LE, Nievergelt CM, et al. Genetic variants associated with sleep disorders. Sleep Med. 2015;16(2):217-224. DOI: 10.1016/j.sleep.2014.11.003.
31. Jansen PR, Watanabe K, Stringer S, et al. Genome-wide analysis of insomnia in 1,331,010 individuals identifies new risk loci and functional pathways. Nat. Genet. 2019;51(3):394–403. DOI: 10.1038/s41588-018-0333-3.
32. Lane JM, Jones SE, Dashti HS, et al. Biological and clinical insights from genetics of insomnia symptoms. Nat. Genet. 2019;51(3):387–393. DOI: 10.1038/s41588-019-0361-7.
33. Song W, Torous J, Kossowsky J, et al. Genome-wide association analysis of insomnia using data from Partners Biobank. Sci. Rep. 2020;10(1):6928. doi:10.1038/s41598-020-63792-0.
34. Winkelmann J, Schormair B, Lichtner P, et al. Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat. Genet. 2007;39(8):1000–1006. DOI: 10.1038/ng2099.
35. Gafarov VV, Gromova EA, Gagulin IV, et al. Association of sleep disorders with various polymorphic variants of the 5-HTTLPR SNP rs25531 A>G gene in people aged 25–44. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2023;15(1):43–49 (In Russian). DOI: 10.14412/2074-2711-2023-1-43-49.
36. Kripke DF, Shadan FF, Dawson A, et al. Genotyping sleep disorders patients. Psychiatry Investig. 2010;7(1):36-42. DOI: 10.4306/pi.2010.7.1.36.
37. Benedetti F, Dallaspezia S, Fulgosi MC, et al. Actimetric evidence that CLOCK 3111 T/C SNP influences sleep and activity patterns in patients affected by bipolar depression. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2007;144B(5):631–635. DOI: 10.1002/ajmg.b.30475.
38. Raptis DG, Vavougios GD, Siachpazidou DI, et al. Intergenic SNPs in Obstructive Sleep Apnea Syndrome: Revealing Metabolic, Oxidative Stress and Immune-Related Pathways. Diagnostics (Basel). 2021;11(10):1753. DOI: 10.3390/diagnostics11101753.
39. Ban HJ, Kim SC, Seo J, et al. Genetic and metabolic characterization of insomnia. PLoS One. 2011;6(4):e18455. DOI: 10.1371/journal.pone.0018455.
40. Byrne EM, Johnson J, McRae AF, et al. A genome-wide association study of caffeine-related sleep disturbance: confirmation of a role for a common variant in the adenosine receptor. Sleep. 2012;35(7):967–975. DOI: 10.5665/sleep.1962.
41. Stefansson H, Rye DB, Hicks A, et al. A genetic risk factor for periodic limb movements in sleep. N. Engl. J. Med. 2007;357(7):639–647. DOI: 10.1056/NEJMoa072743.
42. Schormair B, Kemlink D, Roeske D, et al. PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome. Nat. Genet. 2008;40(8):946–948. DOI: 10.1038/ng.190.
43. Patel SR, Goodloe R, De G, et al. Association of genetic loci with sleep apnea in European Americans and African-Americans: the Candidate Gene Association Resource (CARe). PLoS One. 2012;7(11):e48836. DOI: 10.1371/journal.pone.0048836.
44. Tafti M, Hor H, Dauvilliers Y, et al. DQB1 locus alone explains most of the risk and protection in narcolepsy with cataplexy in Europe. Sleep. 2014;37(1):19–25. DOI: 10.5665/sleep.3300.
45. Miyagawa T, Kawashima M, Nishida N, et al. Variant between CPT1B and CHKB associated with susceptibility to narcolepsy. Nat. Genet. 2008;40(11):1324–1328. DOI: 10.1038/ng.231.
46. Khor SS, Miyagawa T, Toyoda H, et al. Genome-wide association study of HLA-DQB1*06:02 negative essential hypersomnia. PeerJ. 2013;1:e66. DOI: 10.7717/peerj.66.
47. Hallmayer J, Faraco J, Lin L, et al. Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat. Genet. 2009;41(6):708–711. DOI: 10.1038/ng.372.
48. Miyagawa T, Honda M, Kawashima M, et al. Polymorphism located in TCRA locus confers susceptibility to essential hypersomnia with HLA-DRB1*1501-DQB1*0602 haplotype. J. Hum. Genet. 2010;55(1):63–65. DOI: 10.1038/jhg.2009.118.
49. Han F, Lin L, Li J, et al. TCRA, P2RY11, and CPT1B/CHKB associations in Chinese narcolepsy. Sleep Med. 2012;13(3):269-272. DOI: 10.1016/j.sleep.2011.06.020.
50. Kornum BR, Kawashima M, Faraco J, et al. Common variants in P2RY11 are associated with narcolepsy. Nat. Genet. 2011;43(1):66–71. DOI: 10.1038/ng.734.
51. Faraco J, Lin L, Kornum BR, et al. ImmunoChip study implicates antigen presentation to T cells in narcolepsy. PLoS Genet. 2013;9(2):e1003270. DOI: 10.1371/journal.pgen.1003270.
52. Ollila HM, Sharon E, Lin L, et al. Narcolepsy risk loci outline role of T cell autoimmunity and infectious triggers in narcolepsy. Nat. Commun. 2023;14(1):2709. DOI: 10.1038/s41467-023-36120-z.
53. Denis D, French CC, Rowe R, et al. A twin and molecular genetics study of sleep paralysis and associated factors. J. Sleep Res. 2015;24(4):438–446. DOI: 10.1111/jsr.12282.
54. Jones SE, Tyrrell J, Wood AR, et al. Genome-Wide Association Analyses in 128,266 Individuals Identifies New Morningness and Sleep Duration Loci. PLoS Genet. 2016;12(8):e1006125. DOI: 10.1371/journal.pgen.1006125.
55. Hu Y, Shmygelska A, Tran D, et al. GWAS of 89,283 individuals identifies genetic variants associated with self-reporting of being a morning person. Nat. Commun. 2016;7:10448. DOI: 10.1038/ncomms10448.
56. Kichaev G, Bhatia G, Loh PR, et al. Leveraging Polygenic Functional Enrichment to Improve GWAS Power. Am. J. Hum. Genet. 2019;104(1):65-75. DOI: 10.1016/j.ajhg.2018.11.008.
57. Jones SE, Lane JM, Wood AR, et al. Genome-wide association analyses of chronotype in 697,828 individuals provides insights into circadian rhythms. Nat. Commun. 2019;10(1):343. DOI: 10.1038/s41467-018-08259-7.
58. Noordam R, Bos MM, Wang H, et al. Multi-ancestry sleep-by-SNP interaction analysis in 126,926 individuals reveals lipid loci stratified by sleep duration. Nat. Commun. 2019;10(1):5121. DOI: 10.1038/s41467-019-12958-0.
59. Byrne EM, Gehrman PR, Medland SE, et al. A genome-wide association study of sleep habits and insomnia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2013;162B(5):439-451. DOI: 10.1002/ajmg.b.32168.
60. Krohn L, Wu RYJ, Heilbron K, et al. Fine-Mapping of SNCA in Rapid Eye Movement Sleep Behavior Disorder and Overt Synucleinopathies. Ann. Neurol. 2020;87(4):584-598. DOI: 10.1002/ana.25687.
61. Sakurada K, Konta T, Takahashi S, et al. Circadian Clock Gene Polymorphisms and Sleep-Onset Problems in a Population-Based Cohort Study: The Yamagata Study. Tohoku J. Exp. Med. 2021;255(4):325-331. DOI: 10.1620/tjem.255.325.
62. Cirelli C, Tononi G. Gene expression in the brain across the sleep-waking cycle. Brain Res. 2000;885(2):303- 321. DOI: 10.1016/s0006-8993(00)03008-0.
63. Cirelli C, Tononi G. Differential expression of plasticity-related genes in waking and sleep and their regulation by the noradrenergic system. J. Neurosci. 2000;20(24):9187-9194. DOI: 10.1523/ JNEUROSCI.20-24-09187.2000.
64. Cirelli C, Tononi G. Differences in gene expression between sleep and waking as revealed by mRNA differential display. Brain Res. Mol. Brain Res. 1998;56(1-2):293-305. DOI: 10.1016/s0169-328x(98)00057-6.
65. Cirelli C, Tononi G. Differences in brain gene expression between sleep and waking as revealed by mRNA differential display and cDNA microarray technology. J. Sleep Res. 1999;8(1):44-52. DOI: 10.1046/j.1365-2869.1999.00008.x.
66. Cirelli C, Gutierrez CM, Tononi G. Extensive and divergent effects of sleep and wakefulness on brain gene expression. Neuron. 2004;41(1):35-43. DOI: 10.1016/s0896-6273(03)00814-6.
67. Ackermann K, Plomp R, Lao O, et al. Effect of sleep deprivation on rhythms of clock gene expression and melatonin in humans. Chronobiol. Int. 2013;30(7):901-909. DOI: 10.3109/07420528.2013.784773.
68. Shi S, Hida A, McGuinness OP, et al. Circadian clock gene Bmal1 is not essential; functional replacement with its paralog, Bmal2. Curr. Biol. 2010;20(4):316-321. DOI: 10.1016/j.cub.2009.12.034.
69. Hogenesch JB, Gu YZ, Jain S, Bradfield CA. The basic-helix-loop-helix-PAS orphan MOP3 forms transcriptionally active complexes with circadian and hypoxia factors. Proc. Natl. Acad. Sci. U. S. A. 1998;95(10):5474-5479. DOI: 10.1073/pnas.95.10.5474.
70. Gekakis N, Staknis D, Nguyen HB, et al. Role of the CLOCK protein in the mammalian circadian mechanism. Science. 1998;280(5369):1564-1569. DOI: 10.1126/science.280.5369.1564.
71. Reick M, Garcia JA, Dudley C, McKnight SL. NPAS2: an analog of clock operative in the mammalian forebrain. Science. 2001;293(5529):506-509. DOI: 10.1126/science.1060699.
72. van der Horst GT, Muijtjens M, Kobayashi K, et al. Mammalian Cry1 and Cry2 are essential for maintenance of circadian rhythms. Nature. 1999;398(6728):627-630. DOI: 10.1038/19323.
73. Preitner N, Damiola F, Lopez-Molina L, et al. The orphan nuclear receptor REV-ERBalpha controls circadian transcription within the positive limb of the mammalian circadian oscillator. Cell. 2002;110(2):251-260. DOI: 10.1016/s0092-8674(02)00825-5.
74. Sato TK, Panda S, Miraglia LJ, et al. A functional genomics strategy reveals Rora as a component of the mammalian circadian clock. Neuron. 2004;43(4):527-537. DOI: 10.1016/j.neuron.2004.07.018.
75. Asher G, Gatfield D, Stratmann M, et al. SIRT1 regulates circadian clock gene expression through PER2 deacetylation. Cell. 2008;134(2):317-328. DOI: 10.1016/j.cell.2008.06.050.
76. Chang HC, Guarente L. SIRT1 mediates central circadian control in the SCN by a mechanism that decays with aging. Cell. 2013;153(7):1448-1460. DOI: 10.1016/j.cell.2013.05.027.
77. Lesicka M, Dmitrzak-Weglarz M, Jablonska E, et al. Methylation of melatonin receptors in patients with unipolar and bipolar depression. Mech. Ageing Dev. 2023;211:111776. DOI: 10.1016/j.mad.2023.111776.
78. Gaio DC, Sebastiani AM, do Nascimento Meger M, et al. Association between genetic polymorphisms in the melatonin receptor type 1 A gene and sleep bruxism. Arch. Oral Biol. 2022;144:105565. DOI: 10.1016/j.archoralbio.2022.105565.
79. Ballester-Navarro P, Martínez-Madrid MJ, Javaloyes-Sanchís A, et al. Interplay of circadian clock and melatonin pathway gene variants in adults with autism, intellectual disability and sleep problems. Research in Autism Spectrum Disorders. 2021;81:101715. DOI: 10.1016/j.rasd.2020.101715.
80. Liu T, Borjigin J. N-acetyltransferase is not the rate-limiting enzyme of melatonin synthesis at night. J. Pineal Res. 2005;39(1):91-96. DOI: 10.1111/j.1600-079X.2005.00223.x.
81. Qiu J, Zhang J, Zhou Y, et al. MicroRNA-7 inhibits melatonin synthesis by acting as a linking molecule between leptin and norepinephrine signaling pathways in pig pineal gland. J. Pineal Res. 2019;66(3):e12552. DOI: 10.1111/jpi.12552.
82. Medori R, Tritschler HJ, LeBlanc A, et al. Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene. N. Engl. J. Med. 1992;326(7):444-449. DOI: 10.1056/NEJM199202133260704.
83. Peyron C, Faraco J, Rogers W, et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat. Med. 2000;6(9):991-997. DOI: 10.1038/79690.
84. Tasker R, Rowlands J, Ahmed Z, Di Pietro V. Co-Expression Network Analysis of Micro-RNAs and Proteins in the Alzheimer’s Brain: A Systematic Review of Studies in the Last 10 Years. Cells. 2021;10(12):3479. DOI: 10.3390/cells10123479.
85. Oishi K, Ohyama S, Higo-Yamamoto S. Chronic sleep disorder induced by psychophysiological stress induces glucose intolerance without adipose inflammation in mice. Biochem. Biophys. Res. Commun. 2018;495(4):2616-2621. DOI: 10.1016/j.bbrc.2017.12.158.
86. Terao A, Steininger TL, Hyder K, et al. Differential increase in the expression of heat shock protein family members during sleep deprivation and during sleep. Neuroscience. 2003;116(1):187-200. DOI: 10.1016/s0306-4522(02)00695-4.
87. Möller-Levet CS, Archer SN, Bucca G, et al. Effects of insufficient sleep on circadian rhythmicity and expression amplitude of the human blood transcriptome. Proc. Natl. Acad. Sci. U. S. A. 2013;110(12):E1132-E1141. DOI: 10.1073/pnas.1217154110.
88. Takimoto M, Hamada A, Tomoda A, et al. Daily expression of clock genes in whole blood cells in healthy subjects and a patient with circadian rhythm sleep disorder. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005;289(5):R1273-R1279. DOI: 10.1152/ajpregu.00126.2005.
89. Mithani S, Yun S, Leete JJ, et al. Whole blood transcriptome analysis using RNA sequencing in individuals with insomnia disorder and good sleepers: a pilot study. Sleep Med. 2021;80:1-8. DOI: 10.1016/j.sleep.2021.01.013.
90. Mithani S, Yun S, Pattinson C, et al. 0021 RNA Sequencing Reveals Transcriptomic Changes in Individuals with Insomnia. Sleep. 2020;43(1):A8–A9. DOI: 10.1093/sleep/zsaa056.020.
91. Wåhlin-Larsson B, Ulfberg J, Aulin KP, Kadi F. The expression of vascular endothelial growth factor in skeletal muscle of patients with sleep disorders. Muscle Nerve. 2009;40(4):556-561. DOI: 10.1002/mus.21357.
92. Guzman-Marin R, Ying Z, Suntsova N, et al. Suppression of hippocampal plasticity-related gene expression by sleep deprivation in rats. J. Physiol. 2006;575(Pt 3):807-819. DOI:10.1113/jphysiol.2006.115287.
93. Quera-Salva MA, Kilic-Huck U, Vecchierini MF. Melatonin (MEL) and its use in circadian rhythm sleepwake disorders: Recommendations of the French Medical and Research Sleep Society (SFRMS). Rev. Neurol. (Paris). 2021;177(3):235–244. DOI: 10.1016/j.neurol.2020.07.021.
94. Alamdari AF, Rahnemayan S, Rajabi H, et al. Melatonin as a promising modulator of aging related neurodegenerative disorders: Role of microRNAs. Pharmacol. Res. 2021;173:105839. DOI: 10.1016/j.phrs.2021.105839.
95. Shelton AR, Malow B. Neurodevelopmental Disorders Commonly Presenting with Sleep Disturbances. Neurotherapeutics. 2021;18(1):156-169. DOI: 10.1007/s13311-020-00982-8.
96. Coulson RL, Mourrain P, Wang GX. Sleep deficiency as a driver of cellular stress and damage in neurological disorders. Sleep Med. Rev. 2022;63:101616. DOI: 10.1016/j.smrv.2022.101616.
97. Feybesse C, Chokron S, Tordjman S. Melatonin in Neurodevelopmental Disorders: A Critical Literature Review. Antioxidants (Basel). 2023;12(11):2017. DOI: 10.3390/antiox12112017.
98. Taximaimaiti R, Luo X, Wang XP. Pharmacological and Non-pharmacological Treatments of Sleep Disorders in Parkinson’s Disease. Curr. Neuropharmacol. 2021;19(12):2233-2249. DOI: 10.2174/1570159X19666210517115706.
99. Pressman MR. Disorders of Arousal and timing of the first period of slow wave sleep: Clinical and forensic implications. Sleep Medicine: X. 2022;4:100057. DOI: 10.1016/j.sleepx.2022.100057.
100. Varallo G, Giusti EM, Manna C, et al. Sleep disturbances and sleep disorders as risk factors for chronic postsurgical pain: A systematic review and meta-analysis. Sleep Med. Rev. 2022;63:101630. DOI: 10.1016/j.smrv.2022.101630.
101. Titze-de-Almeida R, Titze-de-Almeida SS, Ferreira GG, et al. microRNA signatures in prodromal REM sleep behavior disorder and early Parkinson’s disease as noninvasive biomarkers. Sleep Med. 2021;78:160-168. DOI: 10.1016/j.sleep.2020.12.012.
102. Koshkina MYu, Gorbunov VV, Aksenova TA, et al. Some ventilation disorders in patients with chronic obstructive pulmonary disease, depending on the presence of obstructive sleep apnea syndrome. Siberian Medical Review. 2015;(6):55-58 (in Russian).
Review
For citations:
Popov A.A., Timechko E.E., Yakimov A.M., Vasilieva A.A., Karnauhov V.V., Dmitrenko D.V. Genetic regulation of circadian rhythms and the sleep/wake cycle in sleep disorders (a systematic review). Vestnik of North-Eastern Federal University. Medical Sciences. 2026;(2):102-123. (In Russ.) https://doi.org/10.25587/2587-5590-2026-2-102-123
Views:
5
JATS XML
Email this article 